Bionomics Limited (BNOX) Stock Analysis

What Bionomics Limited does

Bionomics Limited is an Australian biopharmaceutical company operating at the clinical stage, dedicated to the discovery and advancement of innovative therapeutic compounds. Its research efforts primarily target central nervous system disorders and various cancers, with operations spanning Australia and the United States. A key experimental medicine in its portfolio is BNC210. This compound, which functions as a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, has successfully concluded Phase 2 trials for addressing social anxiety disorder and post-traumatic stress disorder. The company is also developing BNC375, a small molecule therapeutic aimed at improving cognitive function in patients suffering from Alzheimer's disease. Another asset, BNC101, a monoclonal antibody engineered to target cancer stem cells, has concluded its Phase 1 clinical assessment. Moreover, Bionomics is advancing BNC105, a vascular disrupting agent. This agent is currently in Phase 2 clinical trials for the treatment of refractory colorectal cancer and in Phase 1 trials for individuals with relapsed/refractory chronic lymphocytic leukemia. Further bolstering its capabilities, Bionomics Limited maintains a licensing agreement with the pharmaceutical giant Merck & Co., Inc. Established in 1996, the company maintains its corporate headquarters in Eastwood, Australia.

Key metrics

ETFs linked to BNOX

Broad-market and Healthcare sector ETFs an investor holding Bionomics Limited is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BNOX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Bionomics Limited?

Bionomics Limited trades under the ticker BNOX on NASDAQ.

Which exchange is BNOX listed on?

BNOX is listed on NASDAQ.

What sector does Bionomics Limited operate in?

Bionomics Limited is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BNOX in a portfolio?

PortView shows BNOX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.